Categories
Health

F.D.A. Attaches Warning of Uncommon Nerve Syndrome to Johnson & Johnson Covid Vaccine

The database shows only one possible death of a recipient of the Johnson & Johnson shot from Guillain-Barre Syndrome. But the man, a 57-year-old Delaware man, had also suffered a heart attack and stroke in the past four years, which raised questions about his April death.

Although it only requires a single dose and is easier to store than Pfizer and Moderna vaccines, Johnson & Johnson vaccination played only a minor role in the US vaccination campaign. One of the reasons for this is that a plant in Baltimore that was supposed to supply most of the cans in the country was closed for three months for violating the law. The factory, operated by Emergent BioSolutions, a subcontractor, was forced to discard the equivalent of 75 million cans on suspicion of contamination, significantly delaying deliveries to the federal government.

At the same time, demand for the shot collapsed after the safety break in April. At that time, 15 women in the United States and Europe who received the Johnson & Johnson injection were diagnosed with the coagulation disorder; three died. The CDC has now confirmed 38 cases of the disorder.

Regulatory authorities and federal health officials warned that women under the age of 50 in particular should be aware of the “rare but increased” risk of clotting. In the nearly three months since the hiatus ended, only about five million people in the U.S. have taken Johnson & Johnson’s recording, and state officials report that people are much more cautious. Millions of cans distributed by the federal government sit unused and expire this summer.

Alex Gorsky, CEO of Johnson & Johnson, said last month he was still confident that the vaccine, which has been used in 27 countries, will help contain the pandemic overseas. The company has pledged up to 400 million cans to the African Union. Regardless, Covax, the global vaccine exchange program, is set to receive hundreds of millions of doses.

Studies have shown that the Johnson & Johnson syringe protects people from more contagious variants of the coronavirus, including the Delta variant, and is highly effective in preventing severe Covid-19, hospitalizations, and death.

The Food and Drug Administration shares responsibility for vaccines with the CDC, but is solely responsible for issuing product warnings. The Guillain-Barré cases will be discussed at an upcoming meeting of a committee of external experts advising the CDC, the agency said.

Categories
Health

Dr. Kavita Patel says want for a Covid booster shot appears inevitable

Former Obama administration official Dr. Kavita Patel told CNBC on Monday that she expected a Covid vaccine booster to eventually be approved by U.S. regulators due to new, more transmissible variants of coronavirus.

“With the threat of the Delta variant and possibly other looming variants in the future, it seems inevitable that we will need a booster shot,” Patel said on Squawk Box. “But that trillion dollar question is when? It seems like six months is early.”

The comments from Patel, who now works as a family doctor in Washington, came before Pfizer representatives met with federal health officials on Monday to discuss the possible need for Covid booster vaccinations.

Pfizer recently said it is developing a booster shot to combat the highly transmissible Delta variant. In that announcement, the drug maker cited internal data and a study in Israel showing that six months after vaccination, people experience decreased immunity from Pfizer’s two-dose vaccine as Delta becomes the predominant variant in the country.

The company said a third dose of its existing vaccine could help boost immunity. Over the past few months, executives at Pfizer and its German partner BioNTech have said that people will likely need a third dose of vaccine within a year of being fully vaccinated.

However, shortly after Pfizer’s announcement last week, the Centers for Disease Control and Prevention and the Food and Drug Administration released a joint statement stating that fully vaccinated Americans do not currently need a booster vaccination.

This view is supported by health experts like Dr. Ashish Jha, dean of Brown University’s School of Public Health, shared. Jha told CNBC on Friday that he had “seen no evidence yet that anyone needs a third shot”.

While Patel said the data suggests that all three of the Covid vaccines currently approved in the US – the two-dose Pfizer and Moderna vaccines and the Johnson & Johnson single-dose vaccine – offer “more than enough immunity” To protect against severe hospitalization and death, Pfizer did not criticize Pfizer for working on the booster intake.

“I think what we do know is that, even six months ago, immunity declines over time. The question is, how long? ”Said Patel, who served as policy director for the Bureau of Interstate Affairs and Public Engagement in the Obama administration.

People shouldn’t get a third vaccination now, Patel warned.

“We have seen patients who did this accidentally or even deliberately, and they had even more dramatic side effects than the second shot, so I wouldn’t encourage anyone,” said Patel.

Finally, if a booster is recommended by regulators, people should expect the CDC to make recommendations for specific populations, similar to what happened when the vaccine was initially introduced with a focus on high-risk groups. “It won’t come one, it will all,” she said.

Patel said the conversation about booster shots in the US must take into account the global impact, given the difficult introduction in other parts of the world.

“It won’t help the United States if the rest of the world stays unvaccinated and they have the opportunity to get hundreds of millions of doses because we got a booster,” said Patel.

Categories
Health

Most absolutely vaccinated individuals who get Covid delta infections are asymptomatic, WHO says

World Health Organization Director General Tedros Adhanom Ghebreyesus R speaks at a daily briefing in Geneva, Switzerland.

Chen Junxia | Xinhua News Agency | Getty Images

People fully vaccinated against Covid-19 still get the Delta variant, but global health officials said the vaccinations saved most people from getting seriously ill or dying.

“There are reports that vaccinated populations have cases of infection, particularly with the Delta variant,” said Dr. Soumya Swaminathan, the chief scientist of the World Health Organization, at a press conference on Monday. “Most of these are mild or asymptomatic infections.”

However, hospital admissions are on the rise in some parts of the world, especially where vaccination rates are low and the highly contagious Delta variant is spreading, she said.

In the US, officials said virtually all recent hospital admissions and deaths from Covid have occurred in people who have not been vaccinated. Breakthrough infections are rare, and about 75% of people who die or are hospitalized after being vaccinated with Covid are over 65, according to the Centers for Disease Control and Prevention.

“The Delta variant is spreading around the world at a breakneck pace, driving the number of cases and deaths again. However, the same hit does not suffer everywhere,” said WHO Director General Tedros Adhanom Ghebreyesus. “We are in the midst of a growing two-pronged pandemic, with the haves and the have-nots growing divergent within and between countries in high-vaccination locations.”

The variant spreads quickly and infects unprotected and vulnerable people, he said.

Swaminathan warned that vaccinated people can still get Covid and pass it on to others, which is why WHO officials have urged people to continue wearing masks and practice social distancing. “But it certainly greatly reduces your chances of severe hospitalization and death,” she added.

Some studies have shown that those who are infected with Covid after vaccination produce much fewer virus than those who are not vaccinated, which reduces the risk of spreading the virus to others. WHO officials said more studies are needed to understand the impact of the vaccines on transmissibility.

Categories
Health

The Rationing of a Final-Resort Covid Remedy

The results vary widely between hospitals. Overall, however, survival rates have decreased over time, including in large US and European hospitals. From January to May 2020, according to the international register, less than 40 percent of Covid patients died in the first 90 days after the start of ECMO. But more than half died in the months that followed. “The patients seem to be doing significantly worse,” said Dr. Barbaro.

He and his colleagues analyze whether this is related to factors such as new virus variants, less experienced care centers or changes in the treatment of patients before ECMO.

ECMO is offered in a few community hospitals that care for most Americans. The exception is Saint John’s, the Santa Monica facility where the doctor and police sergeant were treated.

An ECMO program started about a year before the advent of Covid-19. The 266-bed hospital provided therapy to 52 Covid patients during the pandemic, much like the entire Northwell healthcare system in New York, which has more than 6,000 hospital and long-term care beds.

The Saint John’s Charity Foundation, supported by the area’s affluent donor base, helped fund the ECMO program and its expansion. The hospital accepted some uninsured Covid patients for ECMO, while those patients elsewhere were often turned down despite a federal program that reimburses hospitals for their treatment.

“There are just so many inequalities,” said Dr. Hammond, director of the Saint John intensive care unit. And for every Covid patient who has survived with ECMO, there are “probably three, four, five people who will die on the waiting list”.

She and other doctors said the pandemic highlighted the need to make ECMO more widely available and less resource intensive. Until then, “we really need a sharing system,” she said. There are allocation systems for transplant organs and trauma care.

Categories
Health

Covid Lambda Variant of Peru: What Scientists Know

Viruses develop. SARS-CoV-2, the virus that causes Covid-19, is no exception. So the emergence of variants is no surprise, and not every new genetic mutation poses a serious threat.

But in recent weeks a growing drum of news coverage has started to sound the alarm about lambda, a variant first discovered in Peru late last year. The variant, initially known as C.37, quickly spread in parts of South America. On June 14, the World Health Organization classified it as an “interesting variant,” which essentially means that experts suspect it could be more dangerous than the original strain.

The prevalence of lambda and its mutations, which are similar to those found in several other highly contagious or worrying variants, make it worth watching, scientists said. But much remains unknown and it is not yet clear how high the risk is.

“I think part of the interest is just due to the fact that there is a new variant that has a new name,” said Nathaniel Landau, a microbiologist at New York University’s Grossman School of Medicine who studies the new coronavirus variants .

“But I don’t think there is any more cause for concern than before we knew about this variant,” added Dr. Landau added. So far, there is no evidence that Lambda will displace Delta, the highly transmissible variant that now dominates most of the world. “There is no reason to believe that this is now anything worse than Delta.”

Pablo Tsukayama, a microbiologist at Cayetano Heredia University in Peru who documented the creation of lambda, agreed. Latin America has “limited capacity” for genomic surveillance and laboratory follow-up studies of new variants, he said. This has created an information gap that is fueling concerns about lambda. “I don’t think it will be worse than anyone else we already have,” he said. “We know so little that it lends itself to a lot of speculation.”

According to a June 15 update by the WHO, lambda had been reported in 29 countries, territories or areas by mid-June. The variant had been detected in 81 percent of the coronavirus samples sequenced in Peru since April, and 31 percent of them in Chile so far, the agency said.

The variant accounts for less than 1 percent of samples sequenced in the United States, according to GISAID, an archive for viral genomic data. Isolated cases have been reported in some other countries.

The variant contains eight notable mutations, including seven in the gene for the spike protein found on the surface of the virus. Some of these mutations come in other flavors and could make the virus more contagious or help bypass the body’s immune response.

But big questions remain unanswered. It’s not yet clear whether lambda is more transmissible than other variants, whether it causes more serious illnesses, or makes vaccines less effective.

Updated

July 11, 2021 at 1:57 p.m. ET

“We don’t have a lot of information compared to the other variants,” says Ricardo Soto-Rifo, a virologist at the University of Chile who studied lambda.

Preliminary laboratory studies that have not yet been published in peer-reviewed journals are cause for concern and reassurance. In these studies, research teams led by Dr. Soto-Rifo and Dr. Landau found that antibodies against Lambda induced by the Pfizer, Moderna and CoronaVac vaccines are less effective than against the original strain, but are still able to neutralize the virus.

The results suggest that these vaccines should still work against lambda, the scientists said. In addition, antibodies aren’t the body’s only defense against the virus; even if they are less strong against lambda, other components of the immune system, such as T cells, can also offer protection.

“This decrease in neutralizing antibodies does not mean that the vaccine is less effective,” said Dr. Soto-Rifo. Real-world studies of how well the vaccines hold up against the variant are still needed, he said.

The researchers also reported that, like several other variants, lambda binds more tightly to cells than the original strain of the virus, making it potentially more transmissible.

Though many questions remain unanswered, Trevor Bedford, an evolutionary biologist at the Fred Hutchinson Cancer Research Center in Seattle, said that he doesn’t find lambda as worrying as Delta and doesn’t expect it to become as dominant worldwide.

“Lambda has been around for a while and it has barely made its way into the US, for example, compared to, for example, Gamma” – the variant first identified in Brazil – “which did pretty well here.” He added, “I think it did entire focus should be on Delta. “

Categories
Health

These are among the new high 5 Covid signs

PeopleImages | E+ | Getty Images

LONDON — When the coronavirus pandemic first emerged in early 2020, governments quickly put out information on what symptoms to look out for, little knowing then that much of the transmission was asymptomatic.

The public was told to look out for a high temperature and a new continuous cough, with a loss of taste or smell, fatigue and a sore throat also named as possible symptoms (some added at different points of the pandemic).

Fast forward to the present day and more symptoms are being reported and recognized. The variation in symptoms has happened over time as several variants of the virus — such as the alpha strain and now the highly transmissible delta variant — have gone on to replace the “original” strain of Covid-19 first discovered in China in late 2019.

Read more: Covid delta variant: Symptoms, spread and what to look out for

Now, an ongoing U.K.-based study which enables the public to enter their Covid symptoms on an app — which enables scientists to then analyze the data — says there are new coronavirus symptoms being widely reported.

The Zoe Covid Symptom study has identified the current top five symptoms that have emerged in recent weeks which seemingly differ depending on whether you’ve been vaccinated, and how many doses you’ve had.

The symptoms highlighted below were first published in late June but still represent the top five symptoms being reported, the Zoe Covid Symptom study told CNBC Wednesday.

The symptoms rankings are based on members of the public’s reports in the app alone and do not take into account which variant caused the virus or demographic information.  

These are the top five symptoms being reported by people who are fully-vaccinated, have had one dose of a vaccine or are unvaccinated.

Symptoms if fully-vaccinated?

The Zoe Covid Symptom study says that, generally, it has seen similar symptoms of Covid-19 being reported overall in the app by people who had and hadn’t been vaccinated.

However, fewer symptoms were reported over a shorter period of time by those who had already had the shot, suggesting that they were falling less seriously ill and getting better more quickly.

Here is the current ranking of Covid symptoms after two vaccinations:

  1. Headache
  2. Runny nose
  3. Sneezing
  4. Sore throat
  5. Loss of smell

The study noted that “traditional” Covid symptoms such as anosmia (loss of smell), fever and shortness of breath ranked way down the list, at five, 12 and 29 respectively. “A persistent cough now ranks at number 8 if you’ve had two vaccine doses, so is no longer the top indicator of having Covid.”

Symptoms after one vaccine dose?

The ranking changes again after one dose of the vaccination as observed below:

  1. Headache
  2. Runny nose
  3. Sore throat
  4. Sneezing
  5. Persistent cough

With the protection from only one vaccine dose, one of the original indicators of a persistent cough has made the top five symptoms, Zoe noted.

Symptoms if you’re unvaccinated?

If you’ve not yet been vaccinated then the symptoms are more recognizable to the traditional ranking, Zoe said, “however we can still observe some changes from when Covid-19 first appeared over a year ago.”

  1. Headache
  2. Sore throat
  3. Runny nose
  4. Fever
  5. Persistent cough

“Loss of smell comes in at number 9 and shortness of breath comes far down the list at number 30, indicating the symptoms as recorded previously are changing with the evolving variants of the virus,” the study found.

Covid cases attributed to the much more contagious delta variant are surging in parts of Europe, the U.K. and the U.S., particularly among young people and the partially vaccinated and unvaccinated.

Read more: The delta variant is spreading in Europe and can’t be stopped

While two doses of the Oxford-AstraZeneca or Pfizer-BioNTech vaccine provide protection against the delta variant, both were significantly less effective after only one shot.

The latest research from Israel on Monday found a decrease in the effectiveness of the Pfizer-BioNTech vaccine in preventing infections and symptomatic illness, coinciding with the spread of delta, but said it remained highly effective in preventing serious illness.

Categories
Health

All vitality crises pale compared to Covid

LONDON – Oil and gas giant BP released its benchmark Statistical Review of World Energy on Thursday, describing 2020 as “a year like no other” due to the impact of the coronavirus pandemic on global energy.

Over the past seven decades, BP claimed to have witnessed some of the most dramatic episodes in the history of the global energy system, including the 1956 Suez Canal crisis, the 1973 oil embargo, the 1979 Iranian revolution and the 2011 Fukushima disaster.

“All moments of great turbulence in global energy,” said Spencer Dale, chief economist at BP, in the report. “But all pale compared to the events of last year.”

To date, more than 185 million Covid-19 cases have been reported worldwide with over 4 million deaths, according to Johns Hopkins University. The actual number of Covid-19 infections and deaths is believed to be far higher – and continues to rise.

The pandemic also resulted in massive economic losses, with global GDP estimated to have fallen by around 3.3% over the past year. This is the biggest peacetime recession since the Great Depression.

The Covid pandemic is having a dramatic impact on global energy. Here are some highlights from the report:

Energy developments

BP said the coronavirus crisis last year caused primary energy and CO2 emissions to fall at the rate they have since World War II. However, the relentless expansion of renewable energies went “relatively unscathed”, with solar energy recording the fastest increase of all time.

The oil and gas company said that global energy demand had fallen by 4.5% and global CO2 emissions from energy consumption had shrunk by 6.3%.

“These declines are enormous by historical standards – the largest declines in both energy demand and carbon emissions since World War II. In fact, the decrease of over 2 Gt CO2 means that last year carbon emissions were back to 2011 levels, ”said Dale.

“It is also noticeable that the carbon intensity of the energy mix – the average carbon emissions per unit of energy used – has decreased by 1.8%, also one of the largest decreases in post-war history,” he added.

For some, the decline in global CO2 emissions briefly raised hopes for so-called “peak carbon”, although the desire to limit global warming – and achieve a key goal of the groundbreaking Paris Agreement – is rapidly deteriorating.

It does so as politicians and business leaders publicly acknowledge the need to transition to a low-carbon society, with policymakers under increasing pressure to deliver on the promises made under the Paris Agreement ahead of this year’s COP26.

“There are worrying signs that last year’s COVID-induced decline in carbon emissions will be short-lived as the global economy recovers and lockdowns are lifted,” said Bernard Looney, CEO of BP, in the report .

“The challenge is to reduce emissions sustainably and in a year-on-year comparison without massively affecting our livelihoods and our everyday lives,” he added.

oil

An overview of Gunvor Petroleum or Rozenburg Refinery in Rotterdam, the Netherlands. Europe’s largest port covers 105 square kilometers (41 square miles) and stretches for 40 kilometers (25 miles).

Dean Mouhtaropoulos | Getty Images News | Getty Images

Oil demand fell most in the US with a decline of 2.3 million barrels, followed by the EU and India with 1.5 million barrels and 480,000 barrels respectively.

BP said global oil production has shrunk by 6.6 million barrels, with two-thirds of that decrease being attributable to the oil producing group OPEC.

The price of international benchmark Brent crude averaged $ 41.84 in 2020, according to the energy giant, its lowest level since 2004. The oil contract was last traded at $ 73.70.

Renewable energy

“Arguably the most important element of the energy system needed to address both aspects of the Paris Agreement – responding to the threat of climate change and supporting sustainable growth – is the need for rapid growth in renewable energy,” said Dale of BP in the report.

Renewable energies, including biofuels and excluding hydropower, rose 9.7% in 2020, BP said. This was slower than the 10-year average of 13.4% year-over-year, but the increase in terms of energy was similar to the years before the pandemic.

Solar power rose by record levels, but wind was found to be the largest contributor to renewable energy growth.

In terms of capacity, solar power grew 127 gigawatts in 2020 while wind power grew 111 gigawatts – nearly double the highest annual increase to date, BP said. “The main driver was China, which has accounted for about half of the global increase in wind and solar capacity,” said Dale.

Speaking of BP’s latest annual Statistical Review of World Energy, Dale said, “The significance of the past 70 years pales when we look at the challenges the energy system will face for the next 10, 20, 30 years as the world continues after that strives to achieve net zero. “

Categories
Health

A Covid Take a look at as Simple as Respiration

People with diabetes, for instance, may have breath that smells fruity or sweet. The odor is caused by ketones, chemicals produced when the body begins to burn fat instead of glucose for energy, a metabolic state known as ketosis.

“The idea that exhaled breath could hold diagnostic potential has been around for some time,” Dr. Davis said. “There are reports in ancient Greek and also ancient Chinese medical training texts that reference a physician’s use of smell as a way to help guide their clinical practice.”

Modern technologies can detect more subtle chemical changes, and machine learning algorithms can identify patterns in breath samples from people with certain diseases. In recent years, scientists have used these methods to identify unique “breathprints” for lung cancer, liver disease, tuberculosis, asthma, inflammatory bowel disease and other conditions. (Dr. Davis and her colleagues have even used V.O.C. profiles to distinguish among cells that had been infected with different strains of flu.)

Before Covid hit, Breathomix had been developing an electronic nose to detect several other respiratory diseases. “We train our system, ‘OK, this is how asthma smells, this how lung cancer smells,” said Rianne de Vries, the company’s chief technology and scientific officer. “So it’s building a big database and finding patterns in big data.”

Last year, the company — and many other researchers in the field — pivoted and began trying to identify a breathprint for Covid-19. During the virus’s initial surge in the spring of 2020, for instance, researchers in Britain and Germany collected breath samples from 98 people who showed up at hospitals with respiratory symptoms. (Participants were asked to exhale into a disposable tube; the researchers then used a syringe to extract a sample of their breath.)

Thirty-one of the patients turned out to have Covid, while the remainder had a variety of diagnoses, including asthma, bacterial pneumonia or heart failure, the researchers reported. The breath samples from people with Covid-19 had higher levels of aldehydes, compounds produced when cells or tissues are damaged by inflammation, and ketones, which fits with research suggesting that the virus may damage the pancreas and cause ketosis.

The Covid patients also had lower levels of methanol, which could be a sign that the virus had inflamed the gastrointestinal system or killed the methanol-producing bacteria that live there. Those breath changes combined “give us a Covid-19 signal,” said Dr. Thomas, a co-author of the study.

Categories
Health

Africa suffers worst surge in Covid instances officers brace for third wave

Employees of the Tunisian community saw them carry a coffin of a COVID-19 victim in the regional hospital during the coronavirus infections.

Jdidi Wassim | SOPA pictures | LightRakete | Getty Images

Africa, where less than 2% of the population is vaccinated against Covid-19, saw the worst increase in cases since the pandemic began last week, the World Health Organization said on Thursday.

The second largest continent saw more than 251,000 new Covid cases in the week ending July 4, a 20% increase from the previous week and a 12% increase from the January high. Active cases in Africa recently surpassed 642,000, beating a peak in the second wave of 528,000 active cases in January, according to a BBC analysis of the Johns Hopkins University data.

“Africa has just marked the continent’s worst pandemic week ever. But the worst is yet to come as the fast-paced third wave continues to accelerate and gain new terrain,” said Dr. Matshidiso Moeti, WHO Regional Director for Africa. “The end of this steep climb is still weeks away. Cases are now doubling every 18 days compared to all 21 days a week ago.”

A security guard takes a man’s temperature at the entrance of a market in Kampala, Uganda on June 20, 2021.

Nicholas Kajoba | Xinhua News Agency | Getty Images

More than sixteen African countries, including Malawi and Senegal, are seeing an increase in new cases. In at least 10 of these countries, the more easily transferable delta variant was found.

Uganda, the Democratic Republic of the Congo, Namibia, Zambia, Rwanda and Tunisia are also experiencing some of the worst spikes in infections, the African Centers for Disease Control and Prevention said. Hospital admissions have increased more than 40% across the continent in recent weeks.

“The alarm bells should ring,” says Dr. Tom Kenyon, Chief Health Officer at Project HOPE and former director of the Center for Global Health at the US CDC. He said Africa’s rate of new cases will soon surpass Asia’s. “Given the horrors we have just seen in India, this should be cause for concern and action.”

He said the Covid emergency in Africa “could get worse than anywhere else we’ve seen”.

South Africa is currently battling a devastating third wave of infections after the Delta variant forced the country to lock it down again on June 28. There is currently a 9 p.m. curfew in the country while less than 1% of its residents are against Covid. are vaccinated. Across the continent, less than 2% of people were vaccinated due to a slow international introduction of vaccines that kept poor countries waiting for life-saving syringes. The 50 million doses administered so far in Africa represent only 1.6% of the doses administered worldwide.

A resident receives a dose of the Covid-19 vaccine AstraZeneca Plc on Tuesday, July 6, 2021 at Mbagathi Hospital in Nairobi, Kenya.

Patrick Meinhardt | Bloomberg | Getty Images

“Vaccination nationalism, in which a handful of nations have taken the lion’s share, is morally unjustifiable and an ineffective strategy for public health,” said WHO Director General Tedros Adhanom Ghebreyesus at a press conference on Wednesday. Tedros also blamed the lack of immunization justice for a “wave of death” in parts of the world, including Africa.

Vaccine deliveries by Covax, a global initiative aimed at ensuring fair access to Covid vaccines, are finally picking up speed after months of delay. More than 1.6 million doses have been shipped to Africa under the initiative and more than 20 million doses of Johnson & Johnson and Pfizer vaccines are expected to be shipped to the continent in the near future. Norway and Sweden will also donate large quantities of vaccines to Africa.

“Some vaccine shipments are expected in August, but nowhere near what is needed,” said Kenyon, who also served as CDC country director in Botswana, Namibia and Ethiopia. “To be successful, vaccine supply must be paired with trained labor and delivery systems.”

A total of 66 million doses were shipped to Africa, of which 40 million doses were delivered under bilateral agreements, 25 million via Covax and 800,000 doses via the African Union’s African Vaccine Acquisition Task Team.

“With much larger Covid-19 vaccine shipments expected in July and August, African countries must use this time to prepare for a rapid roll-out,” said Moeti. By comparison, the US has administered approximately 332 million shots to 55% of its population, according to the US CDC.

Roofing Rolling Mills workers load oxygen tanks onto a vehicle for free delivery to various hospitals in Uganda at their plant in Namanve, Wakiso, Uganda on June 29, 2021.

Badru Katumba | AFP | Getty Images

Categories
Health

Social Isolation in U.S. Rose as Covid Disaster Started to Subside, Analysis Exhibits

Many Americans felt socially isolated during the pandemic, cut off from friends and family while crouching and keeping their distance to protect themselves from infection.

However, new research released Thursday suggests that even as the United States’ public health crisis subsided, communities opened up, and the economy improved, many people’s feelings of isolation have increased.

While the level of social isolation decreased in the spring of the pandemic after the initial shock of the crisis subsided, according to researchers from Harvard, Northeastern, Northwestern and Rutgers universities, it increased sharply in the summer months of last year before turning during the year autumn leveled off again.

People began to feel less disconnected from December to April this year, but the levels of social isolation measured by the researchers increased again this June.

The results suggest that recovery from the pandemic could take a long time and could affect people’s view of their relationships over time. “There were cumulative effects of social isolation,” said David Lazer, professor of political science and computer science at Northeastern and one of the study authors.

To determine social isolation, the researchers asked each person how many people they could count on to care for them when they were sick, to lend them money, to talk to them about a problem when they were depressed, or to help them with the Searching for a job. Someone who said they had only one person or no one to turn to in a certain category was considered socially isolated.

The researchers interviewed a total of 185,223 people in 12 different surveys from April 2020 to June 2021.

Even now, with many more people vaccinated against the coronavirus and becoming much more active in their communities, people may think differently about those they previously relied on. “This break in life can lead to a lot of overwork in our relationships,” said Dr. Lazer, who pointed out the unusual number of people who decided to leave their jobs when the pandemic ends. “It takes a while for the social fabric to heal.”

The increase in the feeling of isolation even when the most severe restrictions were lifted was “noticeable,” said Mario L. Small, a professor of sociology at Harvard University who was not involved in the study. People may have felt they had fewer people to lean on because they physically distanced themselves from a wide network of acquaintances and friends, he said, even as the locks eased.

The researchers found that last summer, despite seeing more people, people’s isolation increased. “Our results show that it is difficult to recover from social isolation and is not just due to increased social contact,” the researchers concluded.

The researchers also point to a strong association between social isolation, particularly among people who said they lacked people to turn to for emotional support, and moderate or severe depression.

Many of the lower-income and less-educated people hardest hit by the pandemic appear to be improving more slowly, said Dr. Lazer. “We are definitely seeing a segregation of fates in terms of socioeconomic status,” he said, with some groups experiencing longer and more uneven recovery.